Cell-free production of target-directed liposomes utilizing membrane localization peptides

IF 11.5 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Kaori Kuno, Yasuhiro Shimane, Yuji Sakai, Yutetsu Kuruma
{"title":"Cell-free production of target-directed liposomes utilizing membrane localization peptides","authors":"Kaori Kuno, Yasuhiro Shimane, Yuji Sakai, Yutetsu Kuruma","doi":"10.1016/j.jconrel.2025.114343","DOIUrl":null,"url":null,"abstract":"Cell-free protein synthesis technology is a powerful tool for the rapid production of bioactive molecules such as antibodies. By combining with liposomes, immobilizing the synthesized proteins onto the liposome membrane leads production of bioactive liposomes within the cell-free reaction. These cell-free approaches can be applied in medical treatment and drug development, however, not many studies have been done to develop it as a highly versatile platform. Here, we explored hydrophobic amino acid sequences that lead hydrophilic proteins onto the liposome membrane and applied them to the co-translational production of bioactive liposomes. The membrane localizing peptides (MLPs) introduced at the N- or C-terminus of small molecular weight antibodies, nanobody, guided the membrane localization onto liposomes. The nanobodies-decorated liposomes specifically bound to cancer cells expressing the target antigen protein, thus suggesting maintaining functional structure on the liposome membrane. The MLPs we discovered can be widely applied to the rapid immobilization of proteins on liposome surfaces, leading to cell-free applications in virus-like particles or RNA therapy.","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"48 1","pages":""},"PeriodicalIF":11.5000,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jconrel.2025.114343","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Cell-free protein synthesis technology is a powerful tool for the rapid production of bioactive molecules such as antibodies. By combining with liposomes, immobilizing the synthesized proteins onto the liposome membrane leads production of bioactive liposomes within the cell-free reaction. These cell-free approaches can be applied in medical treatment and drug development, however, not many studies have been done to develop it as a highly versatile platform. Here, we explored hydrophobic amino acid sequences that lead hydrophilic proteins onto the liposome membrane and applied them to the co-translational production of bioactive liposomes. The membrane localizing peptides (MLPs) introduced at the N- or C-terminus of small molecular weight antibodies, nanobody, guided the membrane localization onto liposomes. The nanobodies-decorated liposomes specifically bound to cancer cells expressing the target antigen protein, thus suggesting maintaining functional structure on the liposome membrane. The MLPs we discovered can be widely applied to the rapid immobilization of proteins on liposome surfaces, leading to cell-free applications in virus-like particles or RNA therapy.

Abstract Image

利用膜定位肽无细胞生产靶向脂质体
无细胞蛋白合成技术是快速生产抗体等生物活性分子的有力工具。通过与脂质体结合,将合成的蛋白质固定在脂质体膜上,在无细胞反应中产生生物活性脂质体。这些无细胞方法可以应用于医学治疗和药物开发,但是,将其开发为一个高度通用的平台的研究并不多。在这里,我们探索了将亲水性蛋白引入脂质体膜的疏水氨基酸序列,并将其应用于生物活性脂质体的共翻译生产。膜定位肽(MLPs)在小分子量抗体纳米体的N端或c端引入,引导膜定位到脂质体上。纳米体修饰的脂质体特异性地与表达靶抗原蛋白的癌细胞结合,从而表明脂质体膜上保持了功能结构。我们发现的mlp可以广泛应用于脂质体表面蛋白质的快速固定化,从而在病毒样颗粒或RNA治疗中实现无细胞应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Controlled Release
Journal of Controlled Release 医学-化学综合
CiteScore
18.50
自引率
5.60%
发文量
700
审稿时长
39 days
期刊介绍: The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信